E. Lévy
Impact in
-
- Neurofibromatosis and Schwannoma Cases
-
- HER2/EGFR in Cancer Research
- Drug Transport and Resistance Mechanisms
Papers in
- Oncology 5
- Bone health and treatments 1
-
- Ovarian cancer diagnosis and treatment 3
- Co-authors
- Jean E. Revuz (1 shared paper)Jacques Zeller (1 shared paper)Alain Créange (1 shared paper)M C Voisin (1 shared paper)Karen Leroy (1 shared paper)Laurent Alexandre Lantieri (1 shared paper)Nadine Martin‐Garcia (1 shared paper)P. Wolkenstein (1 shared paper)
- Journals
- International Journal of Gynecological Cancer (2 papers)British Journal of Cancer (2 papers)European Journal of Cancer (2 papers)Journal of Clinical Oncology (1 paper)The Lancet (1 paper)
- Partner nations
- France
In The Last Decade
E. Lévy
16 papers receiving 304 citations
Peers
Comparison fields: 5 of 36
- Neurology 74
- Oncology 97
- Cancer Research 31
- Pharmacology 22
- Reproductive Medicine 23
Countries citing papers authored by E. Lévy
This map shows the geographic impact of E. Lévy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Lévy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Lévy more than expected).
Fields of papers citing papers by E. Lévy
This network shows the impact of papers produced by E. Lévy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Lévy. The network helps show where E. Lévy may publish in the future.
Co-authors
The 25 scholars most cited alongside E. Lévy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 105 | |
| 2 | Malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1: a clinicopathologic and molecular study of 17 patients. | 2001 | 90 |
| 3 | 2010 | 28 | |
| 4 | 2009 | 20 | |
| 5 | 2000 | 13 | |
| 6 | 1999 | 11 | |
| 7 | 2011 | 11 | |
| 8 | 2005 | 8 | |
| 9 | 2012 | 7 | |
| 10 | 2002 | 6 | |
| 11 | 2005 | 6 | |
| 12 | 1999 | 3 | |
| 13 | 2005 | 3 | |
| 14 | 2013 | 2 | |
| 15 | Antitumor immune response to colorectal cancer antigen detected by the leukocyte adherence inhibition test (LAI) in groups at high risk for colorectal cancer. | 1986 | 1 |
| 16 | 1997 | 1 | |
| 17 | 2012 | 0 |
About E. Lévy
E. Lévy is a scholar working on Oncology, Reproductive Medicine, Cancer Research, Endocrinology, Diabetes and Metabolism and Pulmonary and Respiratory Medicine, having authored 17 papers that have together received 315 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (3 papers), Sarcoma Diagnosis and Treatment (2 papers), Breast Cancer Treatment Studies (2 papers), Diabetic Foot Ulcer Assessment and Management (1 paper), Bone health and treatments (1 paper), Skin Diseases and Diabetes (1 paper), Drug-Induced Adverse Reactions (1 paper) and Prostate Cancer Treatment and Research (1 paper). The work is most often cited by research in Neurology (74 citations), Oncology (97 citations), Cancer Research (31 citations), Pharmacology (22 citations) and Reproductive Medicine (23 citations). E. Lévy has collaborated with scholars based in France. Frequent co-authors include Jean E. Revuz, Jacques Zeller, Alain Créange, M C Voisin, Karen Leroy, Laurent Alexandre Lantieri, Nadine Martin‐Garcia, P. Wolkenstein, Janine Wechsler and Joseph Gligorov. Their work appears in journals such as International Journal of Gynecological Cancer, British Journal of Cancer, European Journal of Cancer, Journal of Clinical Oncology and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.